Cargando…
ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC
BACKGROUND: The nucleoside analog, ARC (NSC 188491) is a recently characterized transcriptional inhibitor that selectively kills cancer cells and has the ability to perturb angiogenesis in vitro. In this study, the mechanism of action of ARC was further investigated by comparing in vitro and in vivo...
Autores principales: | Stockwin, Luke H, Yu, Sherry X, Stotler, Howard, Hollingshead, Melinda G, Newton, Dianne L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651907/ https://www.ncbi.nlm.nih.gov/pubmed/19232100 http://dx.doi.org/10.1186/1471-2407-9-63 |
Ejemplares similares
-
Oxyphenisatin acetate (NSC 59687) triggers a cell starvation response leading to autophagy, mitochondrial dysfunction, and autocrine TNFα-mediated apoptosis
por: Morrison, Bethanie L, et al.
Publicado: (2013) -
NSC-derived exosomes enhance therapeutic effects of NSC transplantation on cerebral ischemia in mice
por: Zhang, Ruolin, et al.
Publicado: (2023) -
Endothelial cell secreted VEGF-C enhances NSC VEGFR3 expression and promotes NSC survival
por: Matta, Rita, et al.
Publicado: (2021) -
NSC800 microprocessor family handbook.
Publicado: (1981) -
Letter to the Member of the NSC and others concerned on the fusion of the NSC with Emulsion Experiments Committee into the new Physics III Committee
por: Ericson, T
Publicado: (1966)